Association of venetoclax-based therapy with increased survival in multiple myeloma (MM) harboring t(11;14): A single-center experience

被引：0
作者：
Ionescu, Filip
Patel, Parth
Thapa, Shrinjaya
Drekolias, Dimitrios
Blue, Brandon Jamaal
Puglianini, Omar Alexis Castaneda
Ochoa-Bayona, Jose L.
Freeman, Ciara L.
Liu, Hien
Hansen, Doris K.
Nishihori, Taiga
Silva, Ariosto
Sudalagunta, Praneeth Reddy
Brayer, Jason B.
Alsina, Melissa
Shain, Kenneth H.
Baz, Rachid C.
Grajales-Cruz, Ariel Felipe
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ S Florida, Tampa, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20055
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcomes of Venetoclax-Based Therapy in Patients with Daratumumab-Refractory t(11;14) Positive Light Chain Amyloidosis
    Orland, Mark
    Dima, Danai
    Ullah, Fauzia
    Awada, Hussein
    Basali, Diana
    Faiman, Beth M.
    Scott, Cynthia
    Mazzoni, Sandra
    Williams, Louis S.
    Samaras, Christy J.
    Valent, Jason
    Anwer, Faiz
    Raza, Shahzad
    Khouri, Jack
    BLOOD, 2023, 142
  • [22] Bortezomid in association therapy in relapsed, refractory multiple myeloma: Experience of a single center
    Buquicchio, C.
    Iacobazzi, A.
    Tarantini, G.
    Ciuffreda, L.
    Desantis, G.
    Santorsola, D.
    Riezzo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 151 - 151
  • [23] Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience
    Piccini, Matteo
    Pilerci, Sofia
    Merlini, Marta
    Grieco, Pietro
    Scappini, Barbara
    Bencini, Sara
    Peruzzi, Benedetta
    Caporale, Roberto
    Signori, Leonardo
    Pancani, Fabiana
    Vannucchi, Alessandro Maria
    Gianfaldoni, Giacomo
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [24] Longterm Lenalidomide therapy in relapsed or refractory multiple myeloma patients - a single-center experience
    Denecke, B.
    Bross-Bach, U.
    Kanz, L.
    Weisel, K.
    ONKOLOGIE, 2010, 33 : 248 - 248
  • [25] Clinical factors determining the survival of multiple myeloma patients with extramedullary disease: a single-center experience
    Bayar, Arda
    Ercan, Tarik
    Yilmaz, Asu Fergun
    Toptas, Tayfur
    Atagunduz, Isik
    Tuglular, Ayse Tulin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S65 - S65
  • [26] Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience
    Tian-Jiao Guo
    Xiao-Jun Huang
    Lei Wen
    Jin Lu
    中华医学杂志英文版, 2017, 130 (02) : 239 - 241
  • [27] Acute Lymphoblastic Leukemia Following Multiple Myeloma Therapy: A Single-Center Experience With 9 Patients
    Baran, Natalia
    Babakhanlou, Rodrick
    Sasaki, Koji
    Takahashi, Koichi
    Short, Nicholas
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Jabbour, Elias J.
    Kantarjian, Hagop M.
    Jain, Nitin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S201 - S202
  • [28] Single-center experience of selinexor-based combination therapies for relapsed multiple myeloma
    Ahmed, Noreen
    Wan, Shucen
    Biran, Noa
    Phull, Pooja
    Ip, Andrew
    Doucette, Kimberley
    Vesole, David
    Siegel, David
    Parmar, Harsh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S158 - S159
  • [29] Two Secondary Primary Malignancies after Bortezomib Therapy for Multiple Myeloma: A Single-center Experience
    Guo, Tian-Jiao
    Huang, Xiao-Jun
    Wen, Lei
    Lu, Jin
    CHINESE MEDICAL JOURNAL, 2017, 130 (02) : 239 - 241
  • [30] Autologous stem cell transplantion (ASCT) for multiple myeloma (MM) with selected graft: A single-center experience.
    Wattad, M
    Baur, FK
    Delfs, C
    Balleisen, L
    Heit, W
    BLOOD, 2001, 98 (11) : 401B - 401B
12345